Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

24/80 NIHR NICE Rolling Call (HSDR Programme)

Opens

31 July 2024

Closes

13:00 on 21 November 2024

Contact

  • For help with your application contact hsdrinfo@nihr.ac.uk
  • For more information about the funding Programme, visit the HSDR Page
  • Got a research idea and not sure how to turn it into a funding application? The free NIHR Research Support Service (RSS) supports researchers in England to apply for funding, and to develop and deliver clinical and applied health, social care and public health research post award. Find out how the RSS can help you.

Supporting Information

Please note that the Word version of the Stage 1 application form is to be used as a guide and to assist with completion of the online application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.

Anyone can submit an idea for a research topic. If you would like to suggest a topic relating to healthcare where you feel more research is needed, please send it to hsdrinfo@nihr.ac.uk.

The Health and Social Care Delivery Research (HSDR) Programme is accepting Stage 1 applications to this funding opportunity. The programme is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated during the last 5 years.

Proposals must be within the remit of the HSDR Programme and the primary outcome measure must be health related. (This call is also open in the Public Health Research (PHR), Efficacy and Mechanism Evaluation (EME), and Health Technology Assessment (HTA) programmes for proposals which fall within the remit of those programmes - applicants should apply directly to the relevant programme).

NICE has recently been working to identify research needs with a particular focus on health inequalities and has identified the following area where more research is needed. Through the NICE rolling call, the HSDR Programme would welcome applications addressing research recommendation number 5 from the following NICE Guidance Depression in adults: treatment and management (NG222), regarding evaluation of the most effective and cost effective methods to promote increased access to, and uptake of, treatments for people who are under-represented in current services.

This could include evaluation of specific models of service delivery, service developments or changes, such as methods designed to remove barriers to access, which are specifically designed to promote access to adults aged 18 years and older, identified with or at risk of depression from the following vulnerable groups:

  • ethnic minority groups
  • older adults
  • LGBTQ groups
  • men
  • people with disabilities

Please note that applicants are welcome to submit an application which addresses any NICE research recommendation from the past 5 years, and are not limited to NG222 for this round.

In order to apply for this funding opportunity you will need to carefully review the following documents:

All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the Research Governance Guidelines before completing your application. Costs incurred by this committee should be included in the budget as appropriate.

Timescales

Any changes to these dates will be emailed to all Lead Applicants with an application in progress.

  • Stage 1 deadline: 1pm on 21 November 2024
  • notification of out of remit/non-competitive decision if unsuccessful: early January 2025
  • notification of Stage 1 shortlisting decision: early February 2025
  • Stage 2 writing window: early February to early April 2025
  • notification of Stage 2 funding decision: early June 2025
  • start date for funded studies: 1 October/1 November 2025